(S)-5-Methyl-4,7-diazaspiro[2.5]octane dihydrochloride CAS:1199792-86-3
(S)-5-Methyl-4,7-diazaspiro[2.5]octane dihydrochloride serves as a valuable scaffold in the development of pharmaceutical agents, particularly in the field of central nervous system (CNS) disorders. Its spiro ring system confers conformational rigidity and stereochemical properties that are advantageous for interacting with biological targets involved in neurological pathways. One significant application of this compound is in the synthesis of chiral ligands and catalysts used in asymmetric synthesis. The spirocyclic structure provides a chiral environment conducive to selective asymmetric reactions, facilitating the production of enantiomerically pure compounds crucial in drug development and chemical synthesis. In medicinal chemistry, (S)-5-Methyl-4,7-diazaspiro[2.5]octane dihydrochloride is investigated for its potential as a therapeutic agent for conditions such as anxiety, depression, and schizophrenia. Its unique molecular architecture and interactions with neurotransmitter receptors make it a promising candidate for modulating CNS activity and addressing neurological disorders. Researchers exploit the reactivity of (S)-5-Methyl-4,7-diazaspiro[2.5]octane dihydrochloride to develop novel drug candidates with improved pharmacological profiles and reduced side effects. By derivatizing the spiro ring system and modifying functional groups, scientists aim to optimize pharmacokinetic properties and enhance therapeutic efficacy. Moreover, (S)-5-Methyl-4,7-diazaspiro[2.5]octane dihydrochloride finds application as a research tool in neuroscience studies, enabling investigations into the molecular mechanisms underlying CNS disorders and the development of targeted therapeutic interventions. In summary, the unique structural features and pharmacological properties of (S)-5-Methyl-4,7-diazaspiro[2.5]octane dihydrochloride position it as a valuable compound in pharmaceutical research and medicinal chemistry. Its role as a chiral scaffold and potential therapeutic agent underscore its importance in drug discovery efforts aimed at addressing neurological disorders and advancing scientific understanding of CNS function.
Composition | C7H15ClN2 |
Assay | 99% |
Appearance | white powder |
CAS No. | 1199792-86-3 |
Packing | Small and bulk |
Shelf Life | 2 years |
Storage | Store in cool and dry area |
Certification | ISO. |